Clinical Trial

Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2025 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this trial is to compare efficacy of xylometazoline nasal drops and adrenaline nasal pack in participants undergoing elective oromaxillofacial surgeries. The main question aim to answer is xylometazoline nasal drops better than adrenaline nasal packing in terms of nasal bleeding during nasotracheal intubation. Researchers are comparing 2 groups of participants. Participants in group Xylometazoline are receiving 0.1% xylometaxoline nasal drops. Participants in group Adrenaline are receiving adrenaline nasal packing.
Trial Details
NCT Number NCT06801522
Lead Sponsor Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Conditions Nasal Bleeding, Nasotracheal Intubation
Enrollment 70 participants
Start Date 2024-12-01
Primary Completion 2025-03 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-01-30